Ionizable Lipid Nanoparticles for Nucleic Acid Cell Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The effective targeted delivery of biologically active substances such as small molecule drugs, proteins, and nucleic acids to cells is hindered by their relative instability and low cell permeability, with existing lipid-containing nanoparticle compositions lacking in safety, efficacy, and specificity.
Innovation Solution
Novel lipid nanoparticle compositions comprising cationic and/or ionizable amino lipids, phospholipids, polyunsaturated lipids, and PEG lipids are developed to enhance delivery efficiency and specificity, utilizing compounds of Formula (I) and (II) to reduce immunogenicity and improve therapeutic index.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nucleic acids are delivered directly to cells, then therapeutic effect is achieved, but cell permeability is insufficient and instability occurs
Solution Approach 1:
Lipid nanoparticle compositions serve as intermediary carriers that protect nucleic acids from degradation and facilitate their delivery into cells. The lipid formulation acts as a mediator between the unstable nucleic acid and the cellular environment, enabling successful gene delivery while maintaining therapeutic integrity.
2Productivity
If cationic lipids are used to enhance cell permeability, then delivery efficiency improves, but immunogenicity increases
Solution Approach 1:
The patent modifies the chemical parameters of cationic lipids by incorporating specific amino groups and adjusting their structure to reduce immunogenicity while maintaining cell permeability. The lipid composition includes cationic components with specific molecular weights and charge densities that optimize delivery efficiency while minimizing immune system activation.
Solution Approach 2:
The formulation combines multiple lipid types including cationic lipids, phospholipids, and cholesterol in optimized ratios to create a composite nanoparticle system. This composite approach balances the high cell permeability provided by cationic lipids with the stabilizing and immunomodulatory properties of other lipid components.
3Ease of operation
If existing lipid nanoparticle compositions are used, then delivery capability is achieved, but safety and specificity are insufficient
Solution Approach 1:
The lipid nanoparticle formulation incorporates specific components with localized functions: cationic lipids for cell membrane interaction, phospholipids for structural integrity, and targeted ligands for specific cell type recognition. This local quality differentiation within the nanoparticle composition enables both general delivery capability and specific target cell selection with improved safety profiles.
Data Source
AI summary
The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.